跳至主要内容
临床试验/NCT05308134
NCT05308134进行中(未招募)不适用

MaxiMoM: Individualized Fortification of Human Milk for Infants Born ≤ 1250 g; a Three Arm Randomized Clinical Trial

The Hospital for Sick Children40 个研究点 分布在 1 个国家目标入组 615 人开始时间: 2021年11月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
615
试验地点
40
主要终点
Cognitive Composite Score

研究概览

简要总结

Very low birth weight infants have increased nutritional needs. Extra nutrients are added to their human milk feeds to help improve their nutritional status, growth and neurodevelopment. Standard fortification of human milk is routine in most neonatal units in North America, but despite the added nutrients, infants are often discharged from hospitals with poor growth, and their neurodevelopment remains suboptimal. Two individualized fortification methods, target and BUN adjustable, have been proposed to improve the nutrient supply to infants. However, there is currently insufficient evidence to support the implementation of individualized fortification or one method over the other. Therefore, this study will randomly assign very low birth weight infants to receive feeds fortified according to standard, target or BUN adjustable fortification methods until the end of the feeding intervention. Feedings will be prepared in milk preparation rooms to ensure caregivers and outcomes assessor remain blinded to feeding allocation. Growth, morbidities, and nutrient intakes will be determined throughout hospitalization and skinfolds assessed at 36 weeks. At 4 months CA, growth and body composition will be determined by air displacement plethysmography on a subset of infants. Neurodevelopment will be assessed using the Bayley Scales of Infant and Toddler Development, at 18-24 months CA.

详细描述

The end of the feeding intervention is defined as: the infant is 36+0 weeks CA, is discharged home, or receives two oral feeds daily for three consecutive days without top-up. The exception to the 36+0 weeks intervention end-date is in the situation where an infant remains hospitalized but has not completed at least four weeks of the feeding intervention (i.e. 4 weeks following Study Day 1).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 21 Days(Child)
性别
All
接受健康志愿者

入选标准

  • ≤1250 g birth weight or Gestational Age <30+0 weeks and <1500 g birth weight.
  • Parental/guardian consent to participate.
  • Consent for the use of pasteurized donor milk if mother's milk is not available.

排除标准

  • Infant received fortifier or formula before Study Day
  • Study Day 1 anticipated to occur after postnatal day
  • Infants with congenital or chromosomal anomalies or brain injury that may affect growth or neurodevelopment.
  • Enrollment in any other clinical study affecting nutritional management during the feeding intervention.
  • Reasonable potential that the infant will be transferred to a NICU where the study protocol will not be continued before they have completed at least 4 weeks of the feeding intervention.

研究组 & 干预措施

Standard fortification

Active Comparator

干预措施: Standard fortification (Other)

Target fortification

Experimental

干预措施: Target fortification (Other)

BUN adjustable fortification

Experimental

干预措施: BUN adjustable fortification (Other)

结局指标

主要结局

Cognitive Composite Score

时间窗: 18-24 months corrected age

Bayley Scales of Infant and Toddler Development

次要结局

  • Language Composite Score(18-24 months CA)
  • Motor Composite Score(18-24 months CA)
  • Weight Gain during the intervention(Study Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first)
  • Length gain during the intervention(Study Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first)
  • Head circumference gain during the intervention(Study Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first)
  • Body composition at the end of the intervention(36 weeks corrected age)
  • Serious Morbidity(Study Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first)
  • Health Economics(Study Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first)
  • Weight at follow-up(4 months corrected age)
  • Length at follow-up(4 months corrected age)
  • Head Circumference at follow-up(4 months corrected age)
  • Body composition at follow-up (approximated)(4 months corrected age)
  • Body composition at follow-up (direct measurement)(4 months corrected age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Deborah O'Connor

Senior Associate Scientist

The Hospital for Sick Children

研究点 (40)

Loading locations...

相似试验